Peer-reviewed articles

Kerner JF, Cazap E, Yach D, et al. Comprehensive cancer control-research & development: knowing what we do and doing what we know. Tumori. 2009;95(5):610-622. doi:10.1177/030089160909500504

Hegarty J, Beirne PV, Walsh E, Comber H, Fitzgerald T, Wallace Kazer M. Radical prostatectomy versus watchful waiting for prostate cancer. Cochrane Database SystRev. 2010;(11)(11):CD006590. doi:10.1002/14651858.CD006590.pub2

Woods LM, Rachet B, Shack L, et al. Survival from twenty adult cancers in the UK and Republic of Ireland in the late twentieth century. Health Stat Q. 2010;(46):5-24. doi:10.1057/hsq.2010.9

Field S, Deady S, Fitzgibbon J, Murphy M, Comber H. Improved malignant melanoma prognosis at a consultant-delivered multidisciplinary pigmented lesion clinic in Cork. Ir Med J. 2010;103(2):40-43.

Drummond FJ, Carsin AE, Sharp L, Comber H. Trends in prostate specific antigen testing in Ireland: lessons from a country without guidelines. Ir J Med Sci. 2010;179(1):43-49. doi:10.1007/s11845-009-0376-7

Doherty G, Walsh P, Sheridan J, et al. Clinical and pathological factors associated with colorectal cancer at the upper extreme of life. J Am Geriatr Soc. 2010;58(4):794-795. doi:10.1111/j.1532-5415.2010.02793.x

on behalf of the EUROCHIP Working Group, Apostol I, Baban A, et al. Cervical Cancer Assessment in Romania under EUROCHIP-2. Tumori. 2010;96(4):545-552. doi:10.1177/030089161009600406

on behalf of the EUROCHIP Working Group, Valerianova Z, Panayotova Y, Amati C, Baili P. Cervical Cancer Screening in Bulgaria - past and Present Experience. Tumori. 2010;96(4):538-544. doi:10.1177/030089161009600405

on behalf of the EUROCHIP Working Group, Veerus P, Arbyn M, Amati C, Baili P. Impact of Implementing a Nationwide Cervical Cancer Screening Program on Female Population Coverage by Pap-Tests in Estonia. Tumori. 2010;96(4):524-528. doi:10.1177/030089161009600403

on behalf of the EUROCHIP Working Group, Viberga I, Engele L, Baili P. Past, Present and Future of the Cervical Cancer Screening in Latvia. Tumori. 2010;96(4):529-537. doi:10.1177/030089161009600404

HAEMACARE Working Group. Manual for coding and reporting haematological malignancies. Tumori. 2010;96(4):i-A32.

Hegarty AC, Carsin AE, Comber H. Geographical analysis of cancer incidence in Ireland: a comparison of two Bayesian spatial models. Cancer Epidemiol. 2010;34(4):373-381. doi:10.1016/j.canep.2010.04.019

Carsin AE, Drummond FJ, Black A, et al. Impact of PSA testing and prostatic biopsy on cancer incidence and mortality: comparative study between the Republic of Ireland and Northern Ireland. Cancer Causes Control. 2010;21(9):1523-1531. doi:10.1007/s10552-010-9581-y

Cook MB, Kamangar F, Whiteman DC, et al. Cigarette Smoking and Adenocarcinomas of the Esophagus and Esophagogastric Junction: A Pooled Analysis From the International BEACON Consortium. J Natl Cancer Inst. 2010;102(17):1344-1353. doi:10.1093/jnci/djq289

Murphy SJ, Anderson LA, Ferguson HR, et al. Dietary antioxidant and mineral intake in humans is associated with reduced risk of esophageal adenocarcinoma but not reflux esophagitis or Barrett’s esophagus. J Nutr. 2010;140(10):1757-1763. doi:10.3945/jn.110.124362

Sharp L, Foll P, Deady S, O’Ceilleachair A, Buicke C, Carsin AE. Where do people with lung cancer die and how is this changing? A population-based study. Ir Med J. 2010;103(9):262-264, 266.

Sant M, Allemani C, Tereanu C, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116(19):3724-3734. doi:10.1182/blood-2010-05-282632

Ladanchuk TC, Johnston BT, Murray LJ, Anderson LA, FINBAR study group. Risk of Barrett’s oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications. Scand J Gastroenterol. 2010;45(12):1397-1403. doi:10.3109/00365521.2010.503968

Cotton MS, Sharp L, Cochran C, et al. After-effects reported by women having follow-up cervical cytology tests in primary care: A cohort study within the TOMBOLA trial. British Journal of General Practice. 2011;61(587):e333-e339. doi:10.3399/bjgp11X578007

Johnson CY, Sharp L, Cotton SC, Harris CA, Gray NM, Little J. Human papillomavirus infection and anxiety: Analyses in women with low-grade cervical cytological abnormalities unaware of their infection status. PLoS ONE. 2011;6(6). doi:10.1371/journal.pone.0021046

Zigon G, Berrino F, Gatta G, et al. Prognoses for head and neck cancers in Europe diagnosed in 1995–1999: a population-based study. Annals of Oncology. 2011;22(1):165-174. doi:10.1093/annonc/mdq306

Sharp L, Cotton S, Gray N, et al. Long-term psychosocial impact of alternative management policies in women with low-grade abnormal cervical cytology referred for colposcopy: a randomised controlled trial. Br J Cancer. 2011;104(2):255-264. doi:10.1038/sj.bjc.6606042

Ó Céilleachair A, Finn C, Deady S, Carsin AE, Sharp L. Have developments in palliative care services impacted on place of death of colorectal cancer patients in Ireland? A population-based study. Ir J Med Sci. 2011;180(1):91-96. doi:10.1007/s11845-010-0607-y

Carsin AE, Sharp L, Comber H. Geographical, urban/rural and socioeconomic variations in nonmelanoma skin cancer incidence: a population-based study in Ireland. Br J Dermatol. 2011;164(4):822-829. doi:10.1111/j.1365-2133.2011.10238.x

Marcos-Gragera R, Allemani C, Tereanu C, et al. Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project. Haematologica. 2011;96(5):720-728. doi:10.3324/haematol.2010.034264